The US Food and Drugs Administration (FDA) on Monday gave its approval to the use of the Pfizer-BioNTech <a href="https://www.wionews.com/topics/coronavirus-vaccine">coronavirus vaccine </a>for children in the age group of 12-15.&nbsp;

"This is a promising development in our fight against the virus," US President <a href="https://www.wionews.com/topics/joe-biden">Joe Biden </a>was quoted as saying by news agency AFP.

Watch |&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/us-has-undercounted-its-covid-deaths-says-anthony-fauci-383965/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

"If you are a parent who wants to protect your child, or a teenager who is interested in getting vaccinated, today's decision is a step closer to that goal."

In the period between March 1, 2020, and April 30, 2021, US Centers for Disease Control and Prevention reported some 1.5 million <a href="https://www.wionews.com/topics/coronavirus">coronavirus </a>cases in the 11-17 age group, the FDA said.&nbsp;

Generally, the impact of the virus is milder in children, but it can transmit into older, more vulnerable adults.&nbsp;

Also read | <a href="http://wionews.com/world/an-italian-woman-received-six-doses-of-pfizer-covid-vaccine-what-happened-next-384146">An Italian woman received six doses of Pfizer Covid vaccine. What happened next?</a>

Pfizer and BioNTech in March said that their two-dose vaccination drug showed high efficacy in a trial of 2,260 12 to 15-year-olds.

The US president last week underscored the importance of expanding vaccinations to children aged 12 to 15 and said the officials were "ready to move immediately" once the approval is given.&nbsp;

Biden said about 20,000 pharmacies in the US were ready to begin to vaccinate adolescents and jabs will also be provided to paediatricians. 
&nbsp;

The US Food and Drugs Administration (FDA) on Monday gave its approval to the use of the Pfizer-BioNTech coronavirus vaccine for children in the age group of 12-15.

The US Food and Drugs Administration (FDA) on Monday gave its approval to the use of the Pfizer-BioNTech coronavirus vaccine for children in the age group of 12-15. "This is a promising development in our fight against the virus," US President Joe Biden was quoted as saying by news agency AFP. Watch | "If you are a parent who wants to protect your child, or a teenager who is interested in getting vaccinated, today's decision is a step closer to that goal." In the period between March 1, 2020, and April 30, 2021, US Centers for Disease Control and Prevention reported some 1.5 million coronavirus cases in the 11-17 age group, the FDA said. Generally, the impact of the virus is milder in children, but it can transmit into older, more vulnerable adults. Also read | An Italian woman received six doses of Pfizer Covid vaccine. What happened next? Pfizer and BioNTech in March said that their two-dose vaccination drug showed high efficacy in a trial of 2,260 12 to 15-year-olds. The US president last week underscored the importance of expanding vaccinations to children aged 12 to 15 and said the officials were "ready to move immediately" once the approval is given. Biden said about 20,000 pharmacies in the US were ready to begin to vaccinate adolescents and jabs will also be provided to paediatricians.

US approves Pfizer-BioNTech's Covid vaccine for children aged 12-15

The European Union is all set to launch a second legal case against AstraZeneca over its delayed deliveries of COVID-19 vaccines. The move is mostly procedural after a first case was launched in April, according to a leading official.

EU to launch new legal action against AstraZeneca over vaccine deliveries

Top W.H.O officials are pushing assumptions and conjectures on vaccine efficacy amid a deadly second wave in India. Instead of speculating vaccine efficacy on virus variants, shouldn't the W.H.O be fighting for universal vaccination? Palki Sharma tells you more.

Gravitas: Is the W.H.O feeding vaccine hesitancy?

Germany has decided to uplift its prioritization on restrictions on the usage of Johnson & Johnson COVID-19 vaccine. J&J jab will be available for all adults for widespread use across the country. The roll-out of the J&J vaccine had been delayed in Germany and other countries in Europe due to blood clot concerns.

J&J COVID-19 vaccine ready for widespread use in Germany

Russia has approved a one-dose 'Sputnik light' COVID-19 vaccine. The slimmed down shot is not as effective as the original vaccine, it has an efficacy of 79.4% compared to 91.6% for the two shots of Sputnik V.

Russia approves one-dose 'Sputnik Light' COVID-19 vaccine

Germany rejected US' proposal to waive patent protection for COVID-19 vaccines and threatens to derail this proposal. German Chancellor Angela Merkel's office said that the protection of intellectual property is a source of innovation and must remain so in the future.

Germany opposes US-backed global waiver on protection for COVID-19 vaccines

Health Minister Jens Spahn has said that Germany will allow AstraZeneca’s COVID-19 vaccine to be administered to adults of all ages and aims to offer 12-18-year-olds a vaccine by the end of August as it seeks to speed up its rollout.

Germany to offer AstraZeneca COVID-19 vaccine to all adults

Canada has authorised the use of the Pfizer COVID-19 vaccine for children between the ages of 12 and older. It is the first country to do so for this age group. The country's health ministry made the decision based on data from phase three clinical trials on children.

Canada authorises Pfizer COVID-19 vaccine for kids age 12 and older

The largest study on the Pfizer-BioNTech <a href="https://www.wionews.com/topics/coronavirus-vaccine">coronavirus vaccine </a>so far has found that the drug provided more than 95 per cent protection against the <a href="https://www.wionews.com/topics/coronavirus">deadly virus</a>, but these numbers significantly drop when only one of the two prescribed doses are taken.&nbsp;

An analysis of public health data from Israel revealed that the vaccine was even very effective for the elderly even at a time when a more infectious English variant was raising concerns.&nbsp;

Watch |&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-pfizers-bumper-profit-from-vaccine-sales-383086/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

In Israel, about 5 million people have received two doses of Pfizer/BioNTech vaccine, making the country one of the leaders in fully vaccinating its adults with more than 70 per cent of the population inoculated.&nbsp;

The study, published in the Lancet medical journal, found that the two shots of the vaccine provide 95.3 per cent protection against infection and 96.7 per cent protection against death seven days after the second dose.&nbsp;

This protection increased to 96.5 and 98 per cent respectively after 14 days.

Also read | <a href="https://www.wionews.com/world/canada-becomes-first-country-to-authorise-pfizer-covid-vaccine-for-kids-age-12-and-up-383033">Canada becomes first country to authorise Pfizer Covid vaccine for kids age 12 and up</a>

However, the study found, that the protection was extremely low when a single dose of Pfizer-BioNTech vaccine is taken.&nbsp;

Between seven and 14 days after taking the first dose, the protection appeared 57.7 per cent against infection and 77 per cent against death.&nbsp;

(With inputs from agencies)

The largest study on the Pfizer-BioNTech coronavirus vaccine so far has found that the drug provided more than 95 per cent protection against the deadly virus, but these numbers significantly drop when only one of the two prescribed doses are taken.

The largest study on the Pfizer-BioNTech coronavirus vaccine so far has found that the drug provided more than 95 per cent protection against the deadly virus, but these numbers significantly drop when only one of the two prescribed doses are taken. An analysis of public health data from Israel revealed that the vaccine was even very effective for the elderly even at a time when a more infectious English variant was raising concerns. Watch | In Israel, about 5 million people have received two doses of Pfizer/BioNTech vaccine, making the country one of the leaders in fully vaccinating its adults with more than 70 per cent of the population inoculated. The study, published in the Lancet medical journal, found that the two shots of the vaccine provide 95.3 per cent protection against infection and 96.7 per cent protection against death seven days after the second dose. This protection increased to 96.5 and 98 per cent respectively after 14 days. Also read | Canada becomes first country to authorise Pfizer Covid vaccine for kids age 12 and up However, the study found, that the protection was extremely low when a single dose of Pfizer-BioNTech vaccine is taken. Between seven and 14 days after taking the first dose, the protection appeared 57.7 per cent against infection and 77 per cent against death. (With inputs from agencies)

Largest study on Pfizer Covid vaccine says drug offers over 95% protection

President Joe Biden's administration has announced that the United States will support an initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) protection for COVID-19 vaccines.

US supports global waiver of intellectual property protection for COVID-19 vaccines

The Biden administration on Wednesday decided to back the India-led fight for a global waiver on patent protections for <a href="https://www.wionews.com/topics/coronavirus-vaccine">coronavirus vaccines</a>.&nbsp;

US Trade Representative Katherine Tai said though intellectual property rights are important for businesses, Washington "supports the waiver of those protections for COVID-19 vaccines".

Watch |&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="http://wionews.com/videos/gravitas-wto-to-consider-vaccine-patent-waiver-again-382815/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

"This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures," &nbsp;she said in a statement, as reported by news agency AFP.&nbsp;

India, which is battling a massive wave of the <a href="https://www.wionews.com/topics/coronavirus">deadly virus</a>, has insisted on the waiver of COVID-19 vaccine patents in the World Trade Organization (WTO) to allow more companies to produce the drug in order to end the pandemic.&nbsp;

World Health Organization (WHO) has welcomed the US decision, with its head Tedros Adhanom Ghebreyesus saying it marked "a monumental moment in the fight against COVID-19."

Also read | <a href="http://wionews.com/india-news/us-lawmakers-launch-freethevaccine-campaign-in-support-of-india-south-africa-382943">US lawmakers launch #FreeTheVaccine campaign in support of India, South Africa</a> &nbsp;

US President <a href="https://www.wionews.com/topics/joe-biden">Joe Biden </a>was under severe pressure to support these waivers as rich nations are being criticised for hoarding the vaccines.&nbsp;

WTO chief Ngozi Okonjo-Iweala on Wednesday called it a "moral and economic issue of our time."

The US trade representative also said that when the supply of vaccines for Americans are secured, Washington will continue efforts "to expand vaccine manufacturing and distribution."

(With inputs from agencies)

The Biden administration on Wednesday decided to back the India-led fight for a global waiver on patent protections for coronavirus vaccines. US Trade Representative Katherine Tai said though intellectual property rights are important for businesses, Washington "supports the waiver of those protections for COVID-19 vaccines".

The Biden administration on Wednesday decided to back the India-led fight for a global waiver on patent protections for coronavirus vaccines. US Trade Representative Katherine Tai said though intellectual property rights are important for businesses, Washington "supports the waiver of those protections for COVID-19 vaccines". Watch | "This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures," she said in a statement, as reported by news agency AFP. India, which is battling a massive wave of the deadly virus, has insisted on the waiver of COVID-19 vaccine patents in the World Trade Organization (WTO) to allow more companies to produce the drug in order to end the pandemic. World Health Organization (WHO) has welcomed the US decision, with its head Tedros Adhanom Ghebreyesus saying it marked "a monumental moment in the fight against COVID-19." Also read | US lawmakers launch #FreeTheVaccine campaign in support of India, South Africa US President Joe Biden was under severe pressure to support these waivers as rich nations are being criticised for hoarding the vaccines. WTO chief Ngozi Okonjo-Iweala on Wednesday called it a "moral and economic issue of our time." The US trade representative also said that when the supply of vaccines for Americans are secured, Washington will continue efforts "to expand vaccine manufacturing and distribution." (With inputs from agencies)

US backs India-led fight to waive Covid vaccines patents

President Joe Biden on Tuesday announced a goal to vaccinate 70% of US adults with at least one COVID-19 jab by the July 4 and said the government would inoculate 12-15-year-olds as soon as allowed.

Biden aims to inoculate 70% US adults with one dose by July 4

According to the Times newspaper report, everyone aged over 50 in Britain will be offered a third COVID-19 vaccination jab in the autumn in an attempt to eradicate the threat from the infection entirely by Christmas.

People aged over 50 to be offered third COVID-19 vaccine shot in Britain

According to reports, the US Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week. The announcement is set to come a month after the company founded the vaccine is already authorized for those age 16 and older, also provided protection for the younger group.

US: FDA to approve Pfizer COVID-19 vaccine for teens by next week

Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19 vaccine, the company’s Chief Executive Officer (CEO) Albert Bourla said on Monday.

Pfizer in talks with Indian govt over expedited approval of COVID-19 vaccine

White House national security adviser Jake Sullivan said that the US is actively looking at ways to potentially ease patent restrictions on coronavirus vaccines. This comes after a group of Democrats sent President Joe Biden a letter asking him to 'prioritize people over pharmaceutical companies.'

Jake Sullivan: US is actively looking at ways to ease COVID-19 vaccines patent

BioNTech said that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm's CEO Ugur Sahin asserted that it was 'in the final stretches' of preparing its submission for European regulatory approval.

BioNTech eyes COVID-19 vaccine for 12-15-year-olds from June in Europe

Several Indian states, including Delhi, have indicated that they may have to delay the third phase of the vaccination drive for all adults in the country as jabs against the Coronavirus may not be immediately available due to shortage of stocks and delay in deliveries.

India: Phase 3 vaccination drive hampered in many states due to vaccine shortage

The Russian developer of the Sputnik V Coronavirus vaccine said that it would sue the Brazilian health regulator Anvisa for defamation, accusing it of knowingly spreading false information.

Sputnik V vaccine developer to sue Brazil's health regulator Anvisa

Pfizer Inc's shipment of COVID-19 vaccine to Mexico this week includes doses made in its US plant, the first of what are expected to be ongoing exports of its shots from the United States.

Pfizer to export COVID-19 shots from its US plant, first doses sent to Mexico

Uber has come up with unique feature in US. The company is introducing a new feature in its app that will allow people to book COVID-19 vaccine appointments and reserve rental cars.

Uber app in US to enable users to book COVID-19 vaccines

Bharat Biotech on Thursday announced that the price of its <a href="https://www.wionews.com/topics/coronavirus-vaccine">coronavirus vaccine </a>Covaxin will be reduced by Rs 200 (USD 2.7) for Indian states and will be available at Rs 400 (USD 5.4) per dose.

The announcement by the Indian drugmaker comes a day after the Serum Institute of India (SII) also lowered its Covid-19 vaccine Covishield price to Rs 300 (USD 4.05) per dose for state governments in a move it described as a "philanthropic gesture".&nbsp;

Watch |&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/indian-expats-hire-private-jets-to-escape-covid-19-crisis-381339/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Covaxin is the Indian vaccine of Bharat Biotech-ICMR and Covishield is the name of AstraZeneca-Oxford University's drug manufactured in India.&nbsp;

"Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of Rs 400/ dose," Bharat Biotech said in a statement.&nbsp;

Also read | <a href="https://www.wionews.com/india-news/private-jets-in-demand-indians-flee-the-country-fly-to-uae-to-escape-covid-surge-381327">Private jets in demand: Indians flee the country, fly to UAE to escape Covid surge</a>

India is currently struggling with the fresh wave of <a href="https://www.wionews.com/topics/coronavirus">Covid-19 </a>and is witnessing record cases on a daily basis.&nbsp;

The country is also facing a shortage of drugs, medical supplies, oxygen and vaccines, but several countries have come forward to solve the crisis.&nbsp;

Meanwhile, India from May 1 will begin its new phase of vaccination drive in which all people over the age of 18 will be permitted to get inoculation. 
&nbsp;

Bharat Biotech on Thursday announced that the price of its coronavirus vaccine Covaxin will be reduced by Rs 200 (USD 2.7) for Indian states and will be available at Rs 400 (USD 5.

Bharat Biotech on Thursday announced that the price of its coronavirus vaccine Covaxin will be reduced by Rs 200 (USD 2.7) for Indian states and will be available at Rs 400 (USD 5.4) per dose. The announcement by the Indian drugmaker comes a day after the Serum Institute of India (SII) also lowered its Covid-19 vaccine Covishield price to Rs 300 (USD 4.05) per dose for state governments in a move it described as a "philanthropic gesture". Watch | Covaxin is the Indian vaccine of Bharat Biotech-ICMR and Covishield is the name of AstraZeneca-Oxford University's drug manufactured in India. "Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of Rs 400/ dose," Bharat Biotech said in a statement. Also read | Private jets in demand: Indians flee the country, fly to UAE to escape Covid surge India is currently struggling with the fresh wave of Covid-19 and is witnessing record cases on a daily basis. The country is also facing a shortage of drugs, medical supplies, oxygen and vaccines, but several countries have come forward to solve the crisis. Meanwhile, India from May 1 will begin its new phase of vaccination drive in which all people over the age of 18 will be permitted to get inoculation.

Bharat Biotech reduces price of Covaxin for Indian state governments

In a move that risks reigniting a spat with London over scarce vaccine supplies, European Union lawyers on Wednesday demanded AstraZeneca immediately deliver COVID-19 vaccines from its factories in Britain.

EU demands access to AstraZeneca in UK in legal battle

According to a study carried out by Public Health England, single dose of a COVID-19 vaccine can reduce household transmission of the virus by up to half. After this British Health Secretary Matt Hancock has urged everybody to get their vaccines as soon as they are eligible.

Study: One dose of vaccine against COVID-19 halves transmission risk

The United States will began sharing its entire pipeline of AstraZeneca vaccines after a federal safety review. 60 million doses are expected to be available for export in the coming month.

US to share its stockpile of AstraZeneca jabs after safety review

The European Union has launched legal action against pharmaceutical giant AstraZeneca over delivery shortfalls of its Coronavirus vaccine. The legal action was launched on behalf of the bloc's 27 member states.

EU launches legal action against AstraZeneca over delayed vaccines deliveries

The Indian vaccine manufacturer Bharat Biotech has released its amended prices as the country aims to open up vaccination drive to all adults from 1 May.

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination

Israel is gearing up for the second round of vaccinations. The focus this time is on 12 to 15-year-olds. Are these vaccines proven to be safe for children? WION brings you a report.

Israel gears up to vaccinate 12 to 15-year-olds

India is suffering a critical shortage of raw materials & accessories to make COVID-19 vaccines. But at the time of crisis US has refused to comment on lifting the on going ban on the export of vaccine raw materials to India.

US silent on lifting ban on vaccine raw materials export to India

US has approved to restart of Johnson & Johnson COVID-19 vaccine roll out after scientific advisers decided its benefits outweigh a rare risk of blood clot.

Johnson & Johnson vaccines to be restarted in US despite rare clot risk

The second <a href="https://www.wionews.com/topics/coronavirus">coronavirus </a>wave shows no sign of abating.

If we see India's number, daily infections set a world record today.

Watch |&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-india-sets-world-record-for-new-wuhan-virus-cases-379346/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

More than 314,000 new cases were recorded in a day, taking the nation's tally to almost 16 million cases.

It is the second-highest in the world.

Also read | <a href="https://www.wionews.com/india-news/indias-new-daily-covid-cases-top-300000-highest-in-the-world-379187">India's new daily Covid cases top 300,000, highest in the world</a>

The worse part is, India is struggling with shortages from medicines to oxygen.

But it's not all bad news as the recoveries bring hope.&nbsp;

Over 13 million people or more than 84 per cent of patients in India have recovered from the deadly virus.&nbsp;

As many as 1.16 per cent or 180,000 people have died.

India's best bet to curb this surge is to vaccinate as many people as possible promptly.&nbsp;

So far, more than 130 million doses have been given.

Not even 0.1 per cent of people got infected after taking the <a href="https://www.wionews.com/topics/coronavirus-vaccine">vaccine shots</a>.

The percentage of people who have been infected is not more than 0.04 per cent, meaning only two to four people out of 10,000 actually got infected after taking the shots.

On May 1, India will open its vaccination programme to all adults above the age of 18.

<h2>What's happening with the world</h2>

Numbers are not as bad as India, but not good either.

The surge in Europe and South America began in March and it's not slowing down.

In all, more than 143 million people have been infected since last year and over three million have died worldwide.

In the last 14 days, the cases have grown by 23 per cent and deaths rose by 14 per cent.

Countries are stepping up vaccination and over 944 million doses have been administered in 170 countries.

The daily average is 16 million doses, but at this rate, we'll take years to achieve global herd immunity.&nbsp;

The EU booked more than a billion shots in advance, but the vaccination campaign has struggled to take off.

And now the bloc is preparing to sue AstraZeneca. Reports say the European Commission will launch legal proceedings against the company. AstraZeneca was supposed to supply at least 300 million doses to the EU, but it has slashed its deliveries by two thirds because of manufacturing and other issues.

Also, vaccine counterfeiting is happening in Poland and Mexico.

Fake Pfizer vaccines are on sale here at a price of 1,000 dollars a shot.

"It was an underground operation, a kind of clinic, which had been made known through various online media," Hugo López-Gatell Ramírez, Mexico's deputy health secretary, said.&nbsp;

"This clinic was found selling what were supposed to be Pfizer vaccines, at exorbitant prices of up to 40,000-50,000 pesos for the vaccine."

Reports say the vials were found in beer coolers.

Some 80 people got the fake Pfizer shot in Mexico.

Fortunately, they were harmless injections, but the prospect is scary.

The cases are rising, countries are squabbling, there is a shortage of vaccines and now fake jabs have become an issue.&nbsp;

The world needs united global leadership to defeat the pandemic, but where are the leaders?

The second coronavirus wave shows no sign of abating. If we see India's number, daily infections set a world record today. Watch | More than 314,000 new cases were recorded in a day, taking the nation's tally to almost 16 million cases.

The second coronavirus wave shows no sign of abating. If we see India's number, daily infections set a world record today. Watch | More than 314,000 new cases were recorded in a day, taking the nation's tally to almost 16 million cases. It is the second-highest in the world. Also read | India's new daily Covid cases top 300,000, highest in the world The worse part is, India is struggling with shortages from medicines to oxygen. But it's not all bad news as the recoveries bring hope. Over 13 million people or more than 84 per cent of patients in India have recovered from the deadly virus. As many as 1.16 per cent or 180,000 people have died. India's best bet to curb this surge is to vaccinate as many people as possible promptly. So far, more than 130 million doses have been given. Not even 0.1 per cent of people got infected after taking the vaccine shots. The percentage of people who have been infected is not more than 0.04 per cent, meaning only two to four people out of 10,000 actually got infected after taking the shots. On May 1, India will open its vaccination programme to all adults above the age of 18. What's happening with the world Numbers are not as bad as India, but not good either. The surge in Europe and South America began in March and it's not slowing down. In all, more than 143 million people have been infected since last year and over three million have died worldwide. In the last 14 days, the cases have grown by 23 per cent and deaths rose by 14 per cent. Countries are stepping up vaccination and over 944 million doses have been administered in 170 countries. The daily average is 16 million doses, but at this rate, we'll take years to achieve global herd immunity. The EU booked more than a billion shots in advance, but the vaccination campaign has struggled to take off. And now the bloc is preparing to sue AstraZeneca. Reports say the European Commission will launch legal proceedings against the company. AstraZeneca was supposed to supply at least 300 million doses to the EU, but it has slashed its deliveries by two thirds because of manufacturing and other issues. Also, vaccine counterfeiting is happening in Poland and Mexico. Fake Pfizer vaccines are on sale here at a price of 1,000 dollars a shot. "It was an underground operation, a kind of clinic, which had been made known through various online media," Hugo López-Gatell Ramírez, Mexico's deputy health secretary, said. "This clinic was found selling what were supposed to be Pfizer vaccines, at exorbitant prices of up to 40,000-50,000 pesos for the vaccine." Reports say the vials were found in beer coolers. Some 80 people got the fake Pfizer shot in Mexico. Fortunately, they were harmless injections, but the prospect is scary. The cases are rising, countries are squabbling, there is a shortage of vaccines and now fake jabs have become an issue. The world needs united global leadership to defeat the pandemic, but where are the leaders?

India, world struggle with COVID-19 infections and concerns are endless